$CBDY
Target Group Inc.

2024 Q3 Form 10-Q Financial Statement

#000141057824001241 Filed on August 08, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q2
Revenue $541.1K $2.275M
YoY Change -48.28% 199.74%
Cost Of Revenue $173.0K $806.2K
YoY Change -61.91% 118.32%
Gross Profit $368.1K $1.469M
YoY Change -37.82% 276.89%
Gross Profit Margin 68.03% 64.56%
Selling, General & Admin $343.2K
YoY Change 34.6%
% of Gross Profit 23.37%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $206.6K $203.7K
YoY Change -13.1% -11.27%
% of Gross Profit 56.13% 13.87%
Operating Expenses $605.9K $567.7K
YoY Change -6.57% 13.43%
Operating Profit -$237.8K $901.2K
YoY Change 320.83% -913.87%
Interest Expense -$271.1K
YoY Change -173.44%
% of Operating Profit -30.08%
Other Income/Expense, Net -$291.2K -$234.5K
YoY Change -3.04% -121.82%
Pretax Income -$529.0K $666.7K
YoY Change 48.24% -30.83%
Income Tax
% Of Pretax Income
Net Earnings -$529.0K $666.7K
YoY Change 48.24% -30.83%
Net Earnings / Revenue -97.75% 29.3%
Basic Earnings Per Share $0.00 $0.00
Diluted Earnings Per Share $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 617.0M 617.0M
Diluted Shares Outstanding 617.0M 617.0M

Balance Sheet

Concept 2024 Q3 2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.734M
YoY Change 65.46%
Cash & Equivalents $1.293M $1.742M
Short-Term Investments
Other Short-Term Assets $49.68K
YoY Change -3.27%
Inventory $1.010M $527.6K
Prepaid Expenses $41.86K $41.28K
Receivables $46.23K $472.8K
Other Receivables $38.74K
Total Short-Term Assets $2.592M $2.823M
YoY Change 0.25% -3.37%
LONG-TERM ASSETS
Property, Plant & Equipment $4.686M $4.811M
YoY Change -13.67% -16.67%
Goodwill $264.0K $260.4K
YoY Change 0.16% -3.27%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $4.993M $5.115M
YoY Change -13.04% -16.11%
TOTAL ASSETS
Total Short-Term Assets $2.592M $2.823M
Total Long-Term Assets $4.993M $5.115M
Total Assets $7.585M $7.938M
YoY Change -8.91% -11.98%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.712M
YoY Change 434.91%
Accrued Expenses $134.8K
YoY Change -94.46%
Deferred Revenue
YoY Change
Short-Term Debt $990.00
YoY Change 0.0%
Long-Term Debt Due $7.721M $7.615M
YoY Change 263.2% 394.43%
Total Short-Term Liabilities $13.49M $13.22M
YoY Change 60.41% 64.86%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change -100.0%
Other Long-Term Liabilities $1.112M
YoY Change -13.75%
Total Long-Term Liabilities $1.090M $1.112M
YoY Change -83.91% -85.3%
TOTAL LIABILITIES
Total Short-Term Liabilities $13.49M $13.22M
Total Long-Term Liabilities $1.090M $1.112M
Total Liabilities $14.58M $14.33M
YoY Change -3.96% -8.03%
SHAREHOLDERS EQUITY
Retained Earnings -$31.16M -$30.63M
YoY Change 0.78% 0.22%
Common Stock $61.70K $61.70K
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$6.997M -$6.397M
YoY Change
Total Liabilities & Shareholders Equity $7.585M $7.938M
YoY Change -8.91% -11.98%

Cashflow Statement

Concept 2024 Q3 2024 Q2
OPERATING ACTIVITIES
Net Income -$529.0K $666.7K
YoY Change 48.24% -30.83%
Depreciation, Depletion And Amortization $206.6K $203.7K
YoY Change -13.1% -11.27%
Cash From Operating Activities $981.1K
YoY Change -903.69%
INVESTING ACTIVITIES
Capital Expenditures $20.43K
YoY Change
Acquisitions
YoY Change
Other Investing Activities $36.81K
YoY Change -96.26%
Cash From Investing Activities $16.38K
YoY Change -98.34%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 5.350K
YoY Change -95.28%
NET CHANGE
Cash From Operating Activities 981.1K
Cash From Investing Activities 16.38K
Cash From Financing Activities 5.350K
Net Change In Cash 1.003M
YoY Change 2.79%
FREE CASH FLOW
Cash From Operating Activities $981.1K
Capital Expenditures $20.43K
Free Cash Flow $960.6K
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q4 us-gaap Other Receivable After Allowance For Credit Loss Related Party Type Extensible Enumeration
OtherReceivableAfterAllowanceForCreditLossRelatedPartyTypeExtensibleEnumeration
http://fasb.org/us-gaap/2024#RelatedPartyMember
CY2023Q4 us-gaap Accounts Payable Current Related Party Type Extensible Enumeration
AccountsPayableCurrentRelatedPartyTypeExtensibleEnumeration
http://fasb.org/us-gaap/2024#RelatedPartyMember
CY2023Q2 us-gaap Interest Expense Operating Related Party Type Extensible Enumeration
InterestExpenseOperatingRelatedPartyTypeExtensibleEnumeration
http://fasb.org/us-gaap/2024#RelatedPartyMember
us-gaap Interest Expense Operating Related Party Type Extensible Enumeration
InterestExpenseOperatingRelatedPartyTypeExtensibleEnumeration
http://fasb.org/us-gaap/2024#RelatedPartyMember
CY2024Q2 us-gaap Interest Expense Operating Related Party Type Extensible Enumeration
InterestExpenseOperatingRelatedPartyTypeExtensibleEnumeration
http://fasb.org/us-gaap/2024#RelatedPartyMember
CY2024Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
1000000
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
1000000
dei Entity Central Index Key
EntityCentralIndexKey
0001586554
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Trading Symbol
TradingSymbol
CBDY
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
617025999
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
617025999
CY2024Q2 us-gaap Other Receivable After Allowance For Credit Loss Related Party Type Extensible Enumeration
OtherReceivableAfterAllowanceForCreditLossRelatedPartyTypeExtensibleEnumeration
http://fasb.org/us-gaap/2024#RelatedPartyMember
CY2024Q2 us-gaap Accounts Payable Current Related Party Type Extensible Enumeration
AccountsPayableCurrentRelatedPartyTypeExtensibleEnumeration
http://fasb.org/us-gaap/2024#RelatedPartyMember
CY2024Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
us-gaap Interest Expense Operating Related Party Type Extensible Enumeration
InterestExpenseOperatingRelatedPartyTypeExtensibleEnumeration
http://fasb.org/us-gaap/2024#RelatedPartyMember
CY2024Q2 us-gaap Other Receivable After Allowance For Credit Loss Current Related Party Type Extensible Enumeration
OtherReceivableAfterAllowanceForCreditLossCurrentRelatedPartyTypeExtensibleEnumeration
http://fasb.org/us-gaap/2024#RelatedPartyMember
CY2024Q2 us-gaap Other Liability Current Related Party Type Extensible Enumeration
OtherLiabilityCurrentRelatedPartyTypeExtensibleEnumeration
http://fasb.org/us-gaap/2024#RelatedPartyMember
CY2024Q1 cbdy Fair Value Assumptions Term
FairValueAssumptionsTerm
P2Y
dei Amendment Flag
AmendmentFlag
false
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-55066
dei Entity Registrant Name
EntityRegistrantName
TARGET GROUP INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
46-3621499
dei Entity Address Address Line1
EntityAddressAddressLine1
20 Hempstead Drive
dei Entity Address Address Line2
EntityAddressAddressLine2
Hamilton
dei Entity Address City Or Town
EntityAddressCityOrTown
Ontario
dei Entity Address Country
EntityAddressCountry
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
L8W 2E7
dei City Area Code
CityAreaCode
1 905
dei Local Phone Number
LocalPhoneNumber
541-3833
dei Security12g Title
Security12gTitle
Common Stock, Par Value $0.0001
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
617025999
CY2024Q2 us-gaap Cash
Cash
1733714
CY2023Q4 us-gaap Cash
Cash
736323
CY2024Q2 us-gaap Restricted Cash
RestrictedCash
8402
CY2023Q4 us-gaap Restricted Cash
RestrictedCash
8696
CY2024Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
472766
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1031530
CY2024Q2 us-gaap Inventory Net
InventoryNet
527616
CY2023Q4 us-gaap Inventory Net
InventoryNet
1215928
CY2024Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
41279
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
42720
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
55268
CY2024Q2 us-gaap Value Added Tax Receivable Current
ValueAddedTaxReceivableCurrent
35093
CY2024Q2 us-gaap Other Receivables
OtherReceivables
3653
CY2023Q4 us-gaap Other Receivables
OtherReceivables
3781
CY2024Q2 us-gaap Assets Current
AssetsCurrent
2822523
CY2023Q4 us-gaap Assets Current
AssetsCurrent
3094246
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4810856
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5430260
CY2024Q2 us-gaap Goodwill
Goodwill
260373
CY2023Q4 us-gaap Goodwill
Goodwill
269460
CY2024Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
44161
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
46936
CY2024Q2 us-gaap Assets Noncurrent
AssetsNoncurrent
5115390
CY2023Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
5746656
CY2024Q2 us-gaap Assets
Assets
7937913
CY2023Q4 us-gaap Assets
Assets
8840902
CY2024Q2 us-gaap Bank Overdrafts
BankOverdrafts
506
CY2023Q4 us-gaap Bank Overdrafts
BankOverdrafts
506
CY2024Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
2712083
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
2945568
CY2024Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
41644
CY2023Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
43098
CY2023Q4 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
48581
CY2024Q2 cbdy Related Party Payables Net Current
RelatedPartyPayablesNetCurrent
10316351
CY2023Q4 cbdy Related Party Payables Net Current
RelatedPartyPayablesNetCurrent
11415557
CY2024Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
134811
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
127478
CY2024Q2 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
480
CY2023Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
480
CY2024Q2 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
16170
CY2023Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
8021
CY2024Q2 us-gaap Liabilities Current
LiabilitiesCurrent
13222045
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
14589289
CY2024Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1111772
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1223955
CY2024Q2 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
647
CY2023Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
355
CY2024Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
1112419
CY2023Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
1224310
CY2024Q2 us-gaap Liabilities
Liabilities
14334464
CY2023Q4 us-gaap Liabilities
Liabilities
15813599
CY2024Q2 us-gaap Preferred Stock Value
PreferredStockValue
100
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
100
CY2024Q2 us-gaap Common Stock Value
CommonStockValue
61703
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
61703
CY2024Q2 cbdy Shares To Be Issued Total
SharesToBeIssuedTotal
175439
CY2023Q4 cbdy Shares To Be Issued Total
SharesToBeIssuedTotal
175439
CY2024Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
24985697
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
24985697
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-30633852
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-31107348
CY2024Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-985638
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1088288
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-6396551
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-6972697
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
7937913
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
8840902
CY2024Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2275011
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
758984
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4194942
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
758984
CY2024Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
806184
CY2023Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
369261
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1915948
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
369261
CY2024Q2 us-gaap Gross Profit
GrossProfit
1468827
CY2023Q2 us-gaap Gross Profit
GrossProfit
389723
us-gaap Gross Profit
GrossProfit
2278994
us-gaap Gross Profit
GrossProfit
389723
CY2024Q2 us-gaap Professional Fees
ProfessionalFees
67971
CY2023Q2 us-gaap Professional Fees
ProfessionalFees
15883
us-gaap Professional Fees
ProfessionalFees
142514
us-gaap Professional Fees
ProfessionalFees
16106
CY2024Q2 us-gaap Management Fee Expense
ManagementFeeExpense
90173
CY2023Q2 us-gaap Management Fee Expense
ManagementFeeExpense
77191
us-gaap Management Fee Expense
ManagementFeeExpense
187534
us-gaap Management Fee Expense
ManagementFeeExpense
155515
CY2023Q2 cbdy Salary And Wage Nonofficer
SalaryAndWageNonofficer
53083
cbdy Salary And Wage Nonofficer
SalaryAndWageNonofficer
53083
CY2024Q2 us-gaap Legal Fees
LegalFees
40426
CY2023Q2 us-gaap Legal Fees
LegalFees
145987
us-gaap Legal Fees
LegalFees
118085
us-gaap Legal Fees
LegalFees
203927
CY2024Q2 us-gaap Depreciation
Depreciation
203691
CY2023Q2 us-gaap Depreciation
Depreciation
229568
us-gaap Depreciation
Depreciation
439662
us-gaap Depreciation
Depreciation
442254
CY2024Q2 cbdy Operating Lease Income Expense
OperatingLeaseIncomeExpense
-55138
CY2023Q2 cbdy Operating Lease Income Expense
OperatingLeaseIncomeExpense
-28400
cbdy Operating Lease Income Expense
OperatingLeaseIncomeExpense
-109610
cbdy Operating Lease Income Expense
OperatingLeaseIncomeExpense
-17310
CY2024Q2 cbdy General And Administrative Income Expense
GeneralAndAdministrativeIncomeExpense
-110325
CY2023Q2 cbdy General And Administrative Income Expense
GeneralAndAdministrativeIncomeExpense
-56502
cbdy General And Administrative Income Expense
GeneralAndAdministrativeIncomeExpense
-261917
cbdy General And Administrative Income Expense
GeneralAndAdministrativeIncomeExpense
-59131
CY2024Q2 cbdy Travel Expenses
TravelExpenses
-53
cbdy Travel Expenses
TravelExpenses
7362
CY2024Q2 us-gaap Operating Expenses
OperatingExpenses
567671
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
500448
us-gaap Operating Expenses
OperatingExpenses
1266684
us-gaap Operating Expenses
OperatingExpenses
841160
CY2024Q2 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-8189
CY2023Q2 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-4301
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-8441
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-1326
CY2024Q2 cbdy Gain Loss On Settlement Of Liability
GainLossOnSettlementOfLiability
36808
CY2023Q2 cbdy Gain Loss On Settlement Of Liability
GainLossOnSettlementOfLiability
1428185
cbdy Gain Loss On Settlement Of Liability
GainLossOnSettlementOfLiability
36808
cbdy Gain Loss On Settlement Of Liability
GainLossOnSettlementOfLiability
1428185
CY2024Q2 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
273060
CY2023Q2 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
369092
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
622386
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
722698
CY2024Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
22314
CY2023Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-48519
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
71545
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-50794
CY2023Q2 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
12507
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
16782
CY2024Q2 cbdy Allowance Recovery For Sales Tax Recoverable
AllowanceRecoveryForSalesTaxRecoverable
-244
cbdy Allowance Recovery For Sales Tax Recoverable
AllowanceRecoveryForSalesTaxRecoverable
8220
CY2023Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
68115
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
24152
CY2024Q2 cbdy Debt Issuance Costs
DebtIssuanceCosts
12121
CY2023Q2 cbdy Debt Issuance Costs
DebtIssuanceCosts
12354
cbdy Debt Issuance Costs
DebtIssuanceCosts
24560
cbdy Debt Issuance Costs
DebtIssuanceCosts
24757
CY2024Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-234492
CY2023Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1074541
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-538814
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
669544
CY2024Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
666664
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
963816
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
473496
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
218107
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
666664
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
963816
us-gaap Net Income Loss
NetIncomeLoss
473496
us-gaap Net Income Loss
NetIncomeLoss
218107
CY2024Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
9423
CY2023Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-222962
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
102650
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-224981
CY2024Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
676087
CY2023Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
740854
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
576146
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-6874
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.0011
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.0011
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.0016
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.0016
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.0008
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.0008
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.0004
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.0004
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
617025999
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
617025999
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
617025999
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
617025999
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
617025999
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
617025999
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
617025999
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
617025999
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-7072638
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
666664
CY2024Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
9423
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-6396551
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-7307490
CY2023Q2 cbdy Shares To Be Issued As Compensation To Intellectual Property Rights Value
SharesToBeIssuedAsCompensationToIntellectualPropertyRightsValue
48
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
963816
CY2023Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-222962
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-6566588
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-6972697
us-gaap Net Income Loss
NetIncomeLoss
473496
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
102650
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-6396551
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-6559825
cbdy Shares To Be Issued As Compensation To Intellectual Property Rights Value
SharesToBeIssuedAsCompensationToIntellectualPropertyRightsValue
111
us-gaap Net Income Loss
NetIncomeLoss
218107
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-224981
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-6566588
us-gaap Profit Loss
ProfitLoss
473496
us-gaap Profit Loss
ProfitLoss
218107
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-8441
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-1326
cbdy Gain Loss On Settlement Of Liability
GainLossOnSettlementOfLiability
36808
cbdy Gain Loss On Settlement Of Liability
GainLossOnSettlementOfLiability
1428185
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
186
cbdy Allowance For Sales Tax Recoverable
AllowanceForSalesTaxRecoverable
8220
us-gaap Depreciation And Amortization
DepreciationAndAmortization
439662
us-gaap Depreciation And Amortization
DepreciationAndAmortization
442254
us-gaap Operating Lease Expense
OperatingLeaseExpense
102346
us-gaap Operating Lease Expense
OperatingLeaseExpense
119562
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
24152
cbdy Debt Issuance Costs
DebtIssuanceCosts
24560
cbdy Debt Issuance Costs
DebtIssuanceCosts
24757
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-528025
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-53810
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-652221
cbdy Increase Decrease In Sales Tax Recoverable
IncreaseDecreaseInSalesTaxRecoverable
-74438
cbdy Increase Decrease In Sales Tax Recoverable
IncreaseDecreaseInSalesTaxRecoverable
-36448
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-246704
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1320076
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-160868
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-160553
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1755523
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
476930
cbdy Payments For Proceeds From Property Plant And Equipment
PaymentsForProceedsFromPropertyPlantAndEquipment
22949
cbdy Payments For Proceeds From Property Plant And Equipment
PaymentsForProceedsFromPropertyPlantAndEquipment
-5821
us-gaap Payments For Proceeds From Investments
PaymentsForProceedsFromInvestments
340791
cbdy Proceeds From Recoverable Expense
ProceedsFromRecoverableExpense
36808
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
13859
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-334970
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
667846
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
736150
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-736150
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
667846
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
1033232
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
809806
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-36135
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
14380
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
745019
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
232333
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1742116
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1056519
us-gaap Noncash Or Part Noncash Acquisition Intangible Assets Acquired1
NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1
48
us-gaap Noncash Or Part Noncash Acquisition Intangible Assets Acquired1
NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1
114
us-gaap Interest Paid Net
InterestPaidNet
941062
CY2024Q2 us-gaap Area Of Land
AreaOfLand
44000
cbdy Settlement Liabilities Current And Noncurrent
SettlementLiabilitiesCurrentAndNoncurrent
0
CY2024Q2 cbdy Working Capital Deficit
WorkingCapitalDeficit
10399522
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-30633852
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Use of Estimates</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="font-weight:normal;">The preparation of the unaudited condensed consolidated interim financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed consolidated interim financial statements and the reported amounts of revenues and expenses during the reporting periods. Estimates may include those pertaining to accruals. Actual results could differ from those estimates.</span></p>
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4194942
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
758984
cbdy Revenue From Investments In Joint Venture
RevenueFromInvestmentsInJointVenture
791285
CY2024Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
53058
CY2024Q2 us-gaap Inventory Net
InventoryNet
527616
CY2023Q2 us-gaap Inventory Net
InventoryNet
1215928
CY2024Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
271386
CY2024Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
256230
CY2024Q2 us-gaap Inventory Net
InventoryNet
527616
CY2024Q2 cbdy Allowance On Value Added Tax Recoverable
AllowanceOnValueAddedTaxRecoverable
8158
CY2023Q4 cbdy Allowance On Value Added Tax Recoverable
AllowanceOnValueAddedTaxRecoverable
0
CY2017Q3 us-gaap Area Of Land
AreaOfLand
44000
CY2019Q2 us-gaap Area Of Land
AreaOfLand
44000
CY2024Q2 cbdy Depreciation Of Joint Venture Consolidated
DepreciationOfJointVentureConsolidated
22872
CY2023Q2 cbdy Depreciation Of Joint Venture Consolidated
DepreciationOfJointVentureConsolidated
15371
CY2024Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
8894199
CY2024Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
4083343
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4810856
CY2024Q2 cbdy Equity Method Investments Joint Venture
EquityMethodInvestmentsJointVenture
1023608
CY2024Q2 cbdy Receivables From Joint Venture
ReceivablesFromJointVenture
698645
CY2024Q2 cbdy Payable To Joint Venture
PayableToJointVenture
-129185
CY2024Q2 cbdy Gross Investment In Joint Venture
GrossInvestmentInJointVenture
1593068
us-gaap Proceeds From Divestiture Of Interest In Joint Venture
ProceedsFromDivestitureOfInterestInJointVenture
776382
CY2024Q2 cbdy Net Amount Of Investment In Joint Venture
NetAmountOfInvestmentInJointVenture
816686
cbdy Asset Acquired Fair Value Of Accounts Receivables Joint Venture
AssetAcquiredFairValueOfAccountsReceivablesJointVenture
163244
cbdy Asset Acquired Fair Value Of Inventory Joint Venture
AssetAcquiredFairValueOfInventoryJointVenture
1690368
cbdy Asset Acquired Fair Value Of Fixed Assets Joint Venture
AssetAcquiredFairValueOfFixedAssetsJointVenture
534816
cbdy Asset Acquired Fair Value Joint Venture
AssetAcquiredFairValueJointVenture
2388428
cbdy Gain Loss Net On Consolidation Of Joint Venture
GainLossNetOnConsolidationOfJointVenture
1571742
CY2023Q2 cbdy Equity Method Investments Joint Venture
EquityMethodInvestmentsJointVenture
1023608
CY2023Q2 cbdy Receivables From Joint Venture
ReceivablesFromJointVenture
706598
CY2023Q2 cbdy Proceeds From Joint Venture
ProceedsFromJointVenture
776382
CY2023Q2 cbdy Investment In Joint Venture Balance
InvestmentInJointVentureBalance
953824
CY2023Q2 cbdy Gain From Termination Of Joint Venture
GainFromTerminationOfJointVenture
1571742
CY2018Q2 cbdy Business Acquisition Equity Interest Issuable Percentage
BusinessAcquisitionEquityInterestIssuablePercentage
0.4627
cbdy Class Of Warrant Or Right Warrants Exercised During Period
ClassOfWarrantOrRightWarrantsExercisedDuringPeriod
0
CY2024Q2 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
2387314
CY2024Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
5227385
CY2024Q2 us-gaap Long Term Debt
LongTermDebt
7614699
CY2024Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
7614699
CY2024Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
0
CY2024Q2 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
55014
CY2024Q2 us-gaap Deferred Finance Costs Current Net
DeferredFinanceCostsCurrentNet
49022
CY2024Q2 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
5992
CY2024Q2 cbdy Accrued Interest Converted Into Principal
AccruedInterestConvertedIntoPrincipal
657540
CY2024Q2 cbdy Accrued Interest Converted Into Principal
AccruedInterestConvertedIntoPrincipal
900000
CY2024Q2 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
2886380
CY2024Q2 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
2108789
CY2024Q2 us-gaap Line Of Credit
LineOfCredit
2786380
CY2024Q2 us-gaap Line Of Credit
LineOfCredit
2035729
us-gaap Line Of Credit Facility Periodic Payment Interest
LineOfCreditFacilityPeriodicPaymentInterest
417458
us-gaap Line Of Credit Facility Periodic Payment Interest
LineOfCreditFacilityPeriodicPaymentInterest
567044
CY2024Q2 cbdy Line Of Credit Facility Accrued Interest
LineOfCreditFacilityAccruedInterest
414283
CY2024Q2 cbdy Line Of Credit Facility Accrued Interest
LineOfCreditFacilityAccruedInterest
567045
cbdy Number Of Operating Lease Facilities
NumberOfOperatingLeaseFacilities
2
CY2024Q2 us-gaap Lessee Operating Lease Discount Rate
LesseeOperatingLeaseDiscountRate
0.16
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
159656
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
322505
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
325730
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
328987
CY2024Q2 cbdy Lessee Operating Lease Liability Payments Due After Year Four
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour
780861
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
1917739
CY2024Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
671156
CY2024Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
1246583
CY2024Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
134811
CY2024Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1111772
CY2024Q2 cbdy Gross Operating Lease Expense
GrossOperatingLeaseExpense
102346
cbdy Gross Operating Lease Expense
GrossOperatingLeaseExpense
102346
cbdy Gross Operating Lease Expense
GrossOperatingLeaseExpense
119562
CY2024Q2 cbdy Gross Operating Leases Rent And Utilities Expenses
GrossOperatingLeasesRentAndUtilitiesExpenses
-47208
CY2023Q2 cbdy Gross Operating Leases Rent And Utilities Expenses
GrossOperatingLeasesRentAndUtilitiesExpenses
28400
cbdy Gross Operating Leases Rent And Utilities Expenses
GrossOperatingLeasesRentAndUtilitiesExpenses
7264
cbdy Gross Operating Leases Rent And Utilities Expenses
GrossOperatingLeasesRentAndUtilitiesExpenses
-35207
cbdy Recoverable Expenses From Jv Co Related To Rent And Utilities
RecoverableExpensesFromJvCoRelatedToRentAndUtilities
67045
CY2024Q2 cbdy Operating Lease Expenses Total
OperatingLeaseExpensesTotal
55138
CY2023Q2 cbdy Operating Lease Expenses Total
OperatingLeaseExpensesTotal
28400
cbdy Operating Lease Expenses Total
OperatingLeaseExpensesTotal
109610
cbdy Operating Lease Expenses Total
OperatingLeaseExpensesTotal
17310
us-gaap Interest Expense Debt
InterestExpenseDebt
10
us-gaap Interest Expense Debt
InterestExpenseDebt
9
CY2023Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
8021
cbdy Change In Fair Value Of Derivative Liability
ChangeInFairValueOfDerivativeLiability
8149
CY2024Q2 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
16170
CY2024Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2024Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000
CY2024Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
1000000
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
1000000
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
850000000
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
850000000
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
617025999
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
617025999
us-gaap Conversion Of Stock Shares Converted1
ConversionOfStockSharesConverted1
100
cbdy Schedule Of Shares To Be Issued
ScheduleOfSharesToBeIssued
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:29.55%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;width:47.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:29.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Shares</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Amount</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:47.7%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Description</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:29.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;width:47.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">80,000 shares of common stock to be issued as compensation to advisers and consultants. These were recorded at fair value of $52,000, based on the market price of the Company’s stock on the date of issue.</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:29.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">Services</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 115,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 73,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:47.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">35,000 to be issued as settlement of the amount due for website development services amounting to $247,306. The fair value of the shares on the date of settlement was $21,000, resulting in a gain on settlement amounting to $226,306 during the year ended December 31, 2017.</p></td></tr><tr><td style="vertical-align:bottom;width:29.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">Private placements</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 346,296</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 18,787</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;width:47.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">Consideration for private placements with the fair value based on cash proceeds received. Proper allocation between common stock and additional paid-in capital of the amount received will be completed in the period when the shares are issued.</p></td></tr><tr><td style="vertical-align:bottom;width:29.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">Settlement of loans of CannaKorp</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 930,240</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 80,838</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;width:47.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">Refer to Note 9 for details.</p></td></tr><tr><td style="vertical-align:bottom;width:29.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">Agreement with Serious Seeds</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 249,984</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,814</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;width:47.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">As consideration for intellectual property rights granted by Smit. The fair value is based on the market price of the Company’s stock on the date of issue as per the agreement.</p></td></tr><tr><td style="vertical-align:bottom;width:29.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,641,520</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 175,439</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:47.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td></tr></table>
us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
115000
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
73000
CY2024Q2 cbdy Share Based Compensation Share Based Payments Forfeiture Rate
ShareBasedCompensationShareBasedPaymentsForfeitureRate
0
CY2024Q1 cbdy Share Based Compensation Share Based Payments Forfeiture Rate
ShareBasedCompensationShareBasedPaymentsForfeitureRate
0
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
0.350
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
0.350
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
4.61
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
4.33
CY2024Q2 cbdy Fair Value Assumptions Term
FairValueAssumptionsTerm
P2Y
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2024Q2 cbdy Business Acquisition Fair Value Of Equity Interest Issued Or Issuable
BusinessAcquisitionFairValueOfEquityInterestIssuedOrIssuable
173
CY2024Q1 cbdy Business Acquisition Fair Value Of Equity Interest Issued Or Issuable
BusinessAcquisitionFairValueOfEquityInterestIssuedOrIssuable
134
CY2023Q4 cbdy Share Based Compensation Share Based Payments Forfeiture Rate
ShareBasedCompensationShareBasedPaymentsForfeitureRate
0
CY2023Q3 cbdy Share Based Compensation Share Based Payments Forfeiture Rate
ShareBasedCompensationShareBasedPaymentsForfeitureRate
0
CY2023Q2 cbdy Share Based Compensation Share Based Payments Forfeiture Rate
ShareBasedCompensationShareBasedPaymentsForfeitureRate
0
CY2023Q1 cbdy Share Based Compensation Share Based Payments Forfeiture Rate
ShareBasedCompensationShareBasedPaymentsForfeitureRate
0
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
0.350
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
0.350
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
0.350
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
0.300
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
4.38
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
3.99
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
3.42
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
3.05
CY2023Q4 cbdy Fair Value Assumptions Term
FairValueAssumptionsTerm
P2Y
CY2023Q3 cbdy Fair Value Assumptions Term
FairValueAssumptionsTerm
P2Y
CY2023Q2 cbdy Fair Value Assumptions Term
FairValueAssumptionsTerm
P2Y
CY2023Q1 cbdy Fair Value Assumptions Term
FairValueAssumptionsTerm
P2Y
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2023Q4 cbdy Business Acquisition Fair Value Of Equity Interest Issued Or Issuable
BusinessAcquisitionFairValueOfEquityInterestIssuedOrIssuable
158
CY2023Q3 cbdy Business Acquisition Fair Value Of Equity Interest Issued Or Issuable
BusinessAcquisitionFairValueOfEquityInterestIssuedOrIssuable
313
CY2023Q2 cbdy Business Acquisition Fair Value Of Equity Interest Issued Or Issuable
BusinessAcquisitionFairValueOfEquityInterestIssuedOrIssuable
138
CY2023Q1 cbdy Business Acquisition Fair Value Of Equity Interest Issued Or Issuable
BusinessAcquisitionFairValueOfEquityInterestIssuedOrIssuable
160
CY2024Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
10450009
CY2023Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
10400008
cbdy Class Of Warrant Or Right Expired
ClassOfWarrantOrRightExpired
0
CY2023Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
354
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Issues
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues
307
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease
-14
CY2024Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
647
us-gaap Loss Contingency Damages Sought Value
LossContingencyDamagesSoughtValue
1360965
us-gaap Loss Contingency Damages Sought Value
LossContingencyDamagesSoughtValue
1862805
CY2024Q2 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
10735
CY2024Q2 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q2 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q2 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q2 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001410578-24-001241-index-headers.html Edgar Link pending
0001410578-24-001241-index.html Edgar Link pending
0001410578-24-001241.txt Edgar Link pending
0001410578-24-001241-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tmb-20240630.xsd Edgar Link pending
tmb-20240630x10q.htm Edgar Link pending
tmb-20240630xex31d1.htm Edgar Link pending
tmb-20240630xex31d2.htm Edgar Link pending
tmb-20240630xex32d1.htm Edgar Link pending
tmb-20240630_cal.xml Edgar Link unprocessable
tmb-20240630_def.xml Edgar Link unprocessable
tmb-20240630_lab.xml Edgar Link unprocessable
tmb-20240630_pre.xml Edgar Link unprocessable
tmb-20240630x10q_htm.xml Edgar Link completed
FilingSummary.xml Edgar Link unprocessable